Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole
收藏NIAID Data Ecosystem2026-05-16 收录
官方服务：
资源简介：
These are tumor biopsies and corresponding normal samples from patients with early stage ER+/HER2- breast cancer who had received the aromatase inhibitor letrozole for 10-21 days prior to surgery.]]> All patients had early stage ER+/HER2- breast cancer and participated in a clinical trial of neoadjuvant letrozole for 10-21 days prior to surgery.]]>
创建时间：
2015-04-27
